Full Spectrum Software achieves another year of record growth with the addition of 12 major new clients. The range of new clients included cutting edge, VC backed start-ups to the some of the largest medical device makers in the world. Their software technologies were equally diverse, including technologies such as nanofluidics, gene sequencing, radiation therapy, novel EEG systems, specialized web services and image guided surgical planning systems.
Southborough, MA (Vocus) December 8, 2009 -- Full Spectrum Software has achieved another year of record growth with the addition of 12 major new clients. Of the 12 new clients there was an almost equal split between medical device makers and life sciences companies. Of the life sciences companies, one third are venture capital backed companies. While there has been considerably less investment in life sciences by venture capital firms, companies with truly breakthrough technologies are still being funded. The key technology trend amongst the life science companies are the development of novel, ultra-high throughput gene sequencing systems and instruments for extremely high precision molecular analysis. Among the medical device makers a major technology trend is the inclusion of internet or wireless communications in the development of software for their medical devices. Accessing patient data through the internet and remote patient monitoring in general appear to be gaining a great deal of traction with many medical device makers.
Andrew Dallas, Full Spectrum Software’s CEO noted “This year we had the opportunity to work with some of the most advanced software and hardware technology that’s ever been developed. The pace of innovation was truly remarkable in 2009. From nanotechnology, advanced photonics, gene sequencing, laser technology to specialized web services, all of our new clients are right at the cutting edge of technology.”
In regard to medical device software engineering, Andrew Dallas also noted that more powerful software, analyzing, measuring, and manipulating more precise and larger amounts of data from an array of networked devices, benefits physicians and researchers but the key benefit accrues to patients. After all, patients are the ultimate customers. Although advances in hardware will continue to drive value for patients, it is the advances in software that have the potential to provide truly breakthrough value.
Read the full story at http://www.prweb.com/releases/2009gene/11sequencing/prweb3258174.htm.
Copyright©2009 Vocus, Inc.
All rights reserved